carbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium

C119H221N17O19+2 — CID 160531561

IUPACcarbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium
SMILESC=CC(=O)OCC[N+](C)(C)CCCN1C(=O)NC(C)(C)C1=O.C=CC(=O)OCC[N+](C)(C)CCCOC1CC(C)(C)NC(C)(C)C1.C=CC(=O)OC[N+](C)(C)CCCN1C(=O)NC(C)(C)C1=O.C=CC(=O)OC[N+](C)(C)CCCOC1CC(C)(C)NC(C)(C)C1.C=CC[N+](C)(C)CCCOC1CC(C)(C)NC(C)(C)C1.C=CC[N+](C)(C)CCN1C(=O)NC(C)(C)C1=O.C=Cc1ccc([N+](C)(C)CCCN2C(=O)CC(C)(C)C2=O)cc1.[CH3-].[CH3-].[CH3-].[CH3-].[CH3-]
InChIInChI=1S/C19H37N2O3.C19H27N2O2.C18H35N2O3.C17H35N2O.C15H25N3O4.C14H23N3O4.C12H21N3O2.5CH3/c1-8-17(22)24-13-11-21(6,7)10-9-12-23-16-14-18(2,3)20-19(4,5)15-16;1-6-15-8-10-16(11-9-15)21(4,5)13-7-12-20-17(22)14-19(2,3)18(20)23;1-8-16(21)23-14-20(6,7)10-9-11-22-15-12-17(2,3)19-18(4,5)13-15;1-8-10-19(6,7)11-9-12-20-15-13-16(2,3)18-17(4,5)14-15;1-6-12(19)22-11-10-18(4,5)9-7-8-17-13(20)15(2,3)16-14(17)21;1-6-11(18)21-10-17(4,5)9-7-8-16-12(19)14(2,3)15-13(16)20;1-6-8-15(4,5)9-7-14-10(16)12(2,3)13-11(14)17;;;;;/h8,16,20H,1,9-15H2,2-7H3;6,8-11H,1,7,12-14H2,2-5H3;8,15,19H,1,9-14H2,2-7H3;8,15,18H,1,9-14H2,2-7H3;6H,1,7-11H2,2-5H3;6H,1,7-10H2,2-5H3;6H,1,7-9H2,2-5H3;5*1H3/q4*+1;;;;5*-1/p+3
InChIKeyQVPMGMJAPVMENE-UHFFFAOYSA-Q
MW2194.18 g/mol
LogP14.82
Rot. Bonds50

About carbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium

carbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium (PubChem CID 160531561) has the molecular formula C119H221N17O19+2 and a molecular weight of 2194.18 g/mol. Its IUPAC name is carbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium.

Molecular Properties

Compound Namecarbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium
PubChem CID160531561
Molecular FormulaC119H221N17O19+2
Molecular Weight2194.18 g/mol
Exact Mass2192.68
IUPAC Namecarbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium
SMILESC=CC(=O)OCC[N+](C)(C)CCCN1C(=O)NC(C)(C)C1=O.C=CC(=O)OCC[N+](C)(C)CCCOC1CC(C)(C)NC(C)(C)C1.C=CC(=O)OC[N+](C)(C)CCCN1C(=O)NC(C)(C)C1=O.C=CC(=O)OC[N+](C)(C)CCCOC1CC(C)(C)NC(C)(C)C1.C=CC[N+](C)(C)CCCOC1CC(C)(C)NC(C)(C)C1.C=CC[N+](C)(C)CCN1C(=O)NC(C)(C)C1=O.C=Cc1ccc([N+](C)(C)CCCN2C(=O)CC(C)(C)C2=O)cc1.[CH3-].[CH3-].[CH3-].[CH3-].[CH3-]
InChIInChI=1S/C19H37N2O3.C19H27N2O2.C18H35N2O3.C17H35N2O.C15H25N3O4.C14H23N3O4.C12H21N3O2.5CH3/c1-8-17(22)24-13-11-21(6,7)10-9-12-23-16-14-18(2,3)20-19(4,5)15-16;1-6-15-8-10-16(11-9-15)21(4,5)13-7-12-20-17(22)14-19(2,3)18(20)23;1-8-16(21)23-14-20(6,7)10-9-11-22-15-12-17(2,3)19-18(4,5)13-15;1-8-10-19(6,7)11-9-12-20-15-13-16(2,3)18-17(4,5)14-15;1-6-12(19)22-11-10-18(4,5)9-7-8-17-13(20)15(2,3)16-14(17)21;1-6-11(18)21-10-17(4,5)9-7-8-16-12(19)14(2,3)15-13(16)20;1-6-8-15(4,5)9-7-14-10(16)12(2,3)13-11(14)17;;;;;/h8,16,20H,1,9-15H2,2-7H3;6,8-11H,1,7,12-14H2,2-5H3;8,15,19H,1,9-14H2,2-7H3;8,15,18H,1,9-14H2,2-7H3;6H,1,7-11H2,2-5H3;6H,1,7-10H2,2-5H3;6H,1,7-9H2,2-5H3;5*1H3/q4*+1;;;;5*-1/p+3
InChIKeyQVPMGMJAPVMENE-UHFFFAOYSA-Q
XLogP14.82
TPSA354.59 Ų
H-Bond Donors6
H-Bond Acceptors22
Rotatable Bonds50
Heavy Atoms155
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002194.18
LogP ≤ 514.82
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_B(251)', 'substructure': 'N/A'}, {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}

Analyze carbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of carbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium?
The IUPAC name of carbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium (CID 160531561) is carbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium.
What is the SMILES notation for carbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium?
The canonical SMILES for carbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium is C=CC(=O)OCC[N+](C)(C)CCCN1C(=O)NC(C)(C)C1=O.C=CC(=O)OCC[N+](C)(C)CCCOC1CC(C)(C)NC(C)(C)C1.C=CC(=O)OC[N+](C)(C)CCCN1C(=O)NC(C)(C)C1=O.C=CC(=O)OC[N+](C)(C)CCCOC1CC(C)(C)NC(C)(C)C1.C=CC[N+](C)(C)CCCOC1CC(C)(C)NC(C)(C)C1.C=CC[N+](C)(C)CCN1C(=O)NC(C)(C)C1=O.C=Cc1ccc([N+](C)(C)CCCN2C(=O)CC(C)(C)C2=O)cc1.[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].
What is the InChIKey of carbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium?
The InChIKey is QVPMGMJAPVMENE-UHFFFAOYSA-Q. The full InChI is InChI=1S/C19H37N2O3.C19H27N2O2.C18H35N2O3.C17H35N2O.C15H25N3O4.C14H23N3O4.C12H21N3O2.5CH3/c1-8-17(22)24-13-11-21(6,7)10-9-12-23-16-14-18(2,3)20-19(4,5)15-16;1-6-15-8-10-16(11-9-15)21(4,5)13-7-12-20-17(22)14-19(2,3)18(20)23;1-8-16(21)23-14-20(6,7)10-9-11-22-15-12-17(2,3)19-18(4,5)13-15;1-8-10-19(6,7)11-9-12-20-15-13-16(2,3)18-17(4,5)14-15;1-6-12(19)22-11-10-18(4,5)9-7-8-17-13(20)15(2,3)16-14(17)21;1-6-11(18)21-10-17(4,5)9-7-8-16-12(19)14(2,3)15-13(16)20;1-6-8-15(4,5)9-7-14-10(16)12(2,3)13-11(14)17;;;;;/h8,16,20H,1,9-15H2,2-7H3;6,8-11H,1,7,12-14H2,2-5H3;8,15,19H,1,9-14H2,2-7H3;8,15,18H,1,9-14H2,2-7H3;6H,1,7-11H2,2-5H3;6H,1,7-10H2,2-5H3;6H,1,7-9H2,2-5H3;5*1H3/q4*+1;;;;5*-1/p+3.
What are the key properties of carbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium?
carbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium has a molecular weight of 2194.18 g/mol, XLogP of 14.82, 50 rotatable bonds, 6 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for carbanide;2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)ethyl-dimethyl-prop-2-enylazanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium;3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)propyl-dimethyl-(prop-2-enoyloxymethyl)azanium;3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)propyl-(4-ethenylphenyl)-dimethylazanium;dimethyl-(2-prop-2-enoyloxyethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-(prop-2-enoyloxymethyl)-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium;dimethyl-prop-2-enyl-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxypropyl]azanium is sourced from PubChem (CID 160531561), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).